StockData
CollPlant Biotechnologies Ltd logo

CollPlant Biotechnologies Ltd (CLGN) shareholders

CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30
$3.96+0.06 (+1.54%)

Close on Nov 11, 2026Market cap $5.72MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0M
Shares held, 13F filers
Institutional holders
1
0 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
The Loewenbaum 1992 Trust
Joint filing with George Walter Loewenbaum (6.20%)
3,597,04717.50%13D (active) amendmentAug 19, 2026
George Walter Loewenbaum1,256,0569.90%13D (active) amendmentNov 6, 2025
Ami Sagy163,7095.70%13D (active) amendmentSep 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of CLGNValueChange% of portfolio
Parallel Advisors, LLC7–$25–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 202610M0 / 00 / 00M0M
Q1 202610M0 / 01 / 00M0M
Q4 202510M0 / 00 / 00M0M
Q3 202510M0 / 00 / 00M0M
Q2 202510M0 / 00 / 00M0M
Q1 202510M0 / 00 / 00M0M
Q4 202410M0 / 00 / 00M0M
Q3 202410M0 / 00 / 00M0M
Q2 202410M0 / 01 / 00M0M
Q1 202410M0 / 10 / 00M0M
Q4 202310M0 / 01 / 00M0M
Q3 202310M0 / 01 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Yehiel TalChief Executive Officer, Director31,137Mar 19, 2026
Bar Berta AbelisVP Legal206,441Sep 8, 2026
Eran RotemDeputy CEO and CFO516,372Sep 8, 2026
Philippe BensimonVP Regulations and QA2,000Mar 18, 2026
Jasmine SerorVP Product Development45,000Mar 18, 2026
Bowman BagleyVP Commercial North America25,000Mar 18, 2026
Oren FahimipoorVP Operations30,000Mar 18, 2026
Ruty Ben ShlomiDirector66,501Oct 19, 2026
Hugh M. EvansDirector325,554Apr 27, 2026
Elan PennDirector7,500Mar 18, 2026
Avraham HavronDirector10,000Mar 18, 2026
Alisa LaskDirector10,000Mar 18, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Bar Berta Abelis
VP Legal
Sep 3, 2026Award+201,141––206,441
Eran Rotem
Deputy CEO and CFO
Sep 3, 2026Award+510,372––516,372

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-32.5%
From 0M shares
Short volume, 20 days
27.7%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of CollPlant Biotechnologies's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,396,116 shares on Sep 1, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Loewenbaum Lilian S.
10% Stockholder
Oct 27, 202615,550$58.93KOct 27, 2026Open Market Purchase
Ami Sagy
Shareholder
Oct 9, 2025140,000$308.00KOct 10, 2025Private placement from Issuer
Ami Sagy
Shareholder
Sep 22, 202356,098$336.59KSep 21, 2023Ami Sagy
Ami Sagy
Shareholder
Sep 12, 202387,853$633.42KSep 12, 2023Ami Sagy
Sagy Ami
10% Stockholder
Jun 14, 2023110,000$798.60KJun 14, 2023Private Placement

See a number that looks wrong?